Skip to main content
. 2016 Jul 8;6:168. doi: 10.3389/fonc.2016.00168

Figure 2.

Figure 2

Biochemical disease-free survival with intermediate-risk group further stratified into favorable vs. unfavorable risk. There was no significant difference between the low- and favorable intermediate-risk group with follow-up of 9 years. There was a significant (p < 0.0001) difference between the low- and favorable intermediate-risk group vs. the unfavorable intermediate-risk and high-risk patients.